Država: Malta
Jezik: angleščina
Source: Medicines Authority
dexamethasone 0.4 mg/ml
Alapis S.A.
H02AB02
dexamethasone
oral solution
Authorised
2012-05-02
Page 1 of 8 PACKAGE LEAFLET: INFORMATION FOR THE USER DEXAMETHASONE ALAPIS 0.4 MG/ ML ORAL SOLUTION DEXAMETHASONE READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. - If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. In this leaflet: 1. What DEXAMETHASONE ALAPIS is and what it is used for 2. Before you take DEXAMETHASONE ALAPIS 3. How to take DEXAMETHASONE ALAPIS 4. Possible side-effects 5. How to store DEXAMETHASONE ALAPIS 6. Further information 1. WHAT DEXAMETHASONE ALAPIS IS AND WHAT IT IS USED FOR DEXAMETHASONE ALAPIS belongs to a group of medicines called steroids. Their full name is _corticosteroids. _These corticosteroids occur naturally in the body, and help to maintain health and well-being. Boosting your body with extra corticosteroid (such as DEXAMETHASONE ALAPIS) is an effective way to treat various illnesses involving inflammation in the body. DEXAMETHASONE ALAPIS reduces this inflammation, which could otherwise go on making your condition worse. You must take this medicine regularly to get maximum benefit from it. DEXAMETHASONE ALAPIS is used for one of the following: • where natural corticosteroid levels have been reduced and you need replacement therapy • in certain cases where swelling of the brain has occurred • if you are having diagnostic tests for diseases Preberite celoten dokument
Page 1 of 10 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Dexamethasone Alapis 0.4mg/ml Oral Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of solution contains 0.4 mg of dexamethasone (as dexamethasone sodium phosphate). Excipients: Propylene glycol (E1520): 90 mg/ml Liquid maltitol (E965): 275 mg/ml Liquid sorbitol (non-crystallising) (E420): 140 mg/ml Ethanol: 0.24 mg/ml For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Oral Solution. A colourless to faint yellow solution with mint odour. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Dexamethasone is a corticosteroid. It is designed for use in certain endocrine and non-endocrine disorders, in certain cases of cerebral oedema and for diagnostic testing of adrenocortical hyper function. Endocrine disorders: Endocrine exophthalmos. Non-endocrine disorders: Dexamethasone may be used in the treatment of non-endocrine corticosteroid responsive conditions including: Allergy and anaphylaxis: Anaphylaxis. Arteritis collagenosis: Polymyalgia rheumatica, polyarteritis nodosa. Haematological disorders: Haemolytic anaemia (also auto immune), leukaemia, myeloma, idiopathic thrombocytopenic purpura in adults, reticulolymphoproliferative disorders (see also under oncological disorders). Gastroenterological disorders: For treatment during the critical stage in: ulcerative colitis (rectal only); regional enteritis (Crohn's disease), certain forms of hepatitis. Muscular disorders: Polymyositis. Neurological disorders: Raised intra-cranial pressure secondary to cerebral tumours, acute exacerbations of multiple Preberite celoten dokument